Coronary Artery Disease
Conditions
Brief summary
To compare the relative efficacy and safety of the TAXUS Express2 stents and the Cypher stents among a broad, unselected patient population treated in a nationwide, multi-center clinical registry representative of 'real-world,' contemporary clinical practice. A secondary objective is to examine performance of the two stents in pre-specified subgroup populations and examine regional and national patterns in outcomes.
Interventions
Sponsors
Study design
Eligibility
Inclusion criteria
* Patients treated with a TAXUS Express2 stent or a Cypher stent between April 1, 2005 and June 30, 2005.
Exclusion criteria
* Simultaneous treatment with both TAXUS and Cypher stents during the index revascularization. Patients who have undergone previous target vessel(s), stenting procedure within 9 months of the index procedure will be excluded.
Countries
United States